Eliminating hepatitis C among people with HIV

The new, extremely effective Direct acting Antivirals (DAA) have been available and subsidised in Australia since earlier this year. The Kirby Institute is currently recruiting for a study called CEASE which has been designed to eliminate hepatitis C amongst people living with HIV in Australia. People with HIV/hepatitis C co-infection in New South Wales, Queensland, Victoria and South Australia are invited to enrol by contacting Arlen Wilcox, the Project Coordinator on (02) 9385 9970.

Spread the word. Share this post!

Leave A Reply

Your email address will not be published. Required fields are marked *